mode-of-action analysis

Founded in 2021, Cryptobiotix is a preclinical research company that uses its ex vivo SIFR® technology pipeline to study how ingested actives are affected by digestion and interact with the gut microbiome and host. It provides gastrointestinal and gut microbiome research services, simulating the human GI tract and microbiome under biorelevant physiological conditions to deliver validated, predictive insights for clients in food, feed, biotech and pharma.

Read more

colonic fermentationdose-response analysisex vivo SIFR® technologygastrointestinal simulationgut microbiome researchhost-microbiome interaction modellingpreclinical research